Engagements

CRA opines on commercial success of dermatological product

CRA was retained on behalf of a pharmaceutical manufacturer to assess the commercial success of drugs indicated for the treatment of severe acne and the nexus between that success and the patents at issue.

Related Capabilities

Gregory K. Bell
Group Vice President and Life Sciences Practice Leader

Boston
+1-617-425-3357 gbell@crai.com

Intellectual Property
CRA News

CRA consultants named top IP strategists in IAM Strategy 300 2021

Robert Goldman, Daniel McGavock, Dr. Richard Razgaitis, and Larry Rosenberg were recognized in the latest edition of IAM Strategy 300 – The World’s Leading IP...
Antitrust & IP
CRA News

12 CRA consultants named top IP professionals in the 2021 IAM Patent 1000

12 CRA consultants were recognized as leading patent professionals by Intellectual Asset Management (IAM). The IAM Patent 1000 names the best-in-class patent...

Explore our thinking

Intellectual Property
Speaking Engagement

August 4, 2021

Virtual

Beijing Offline Conference - How to obtain the amount of high damage compensation for intellectual property

Qiao Hong is presents during the session titled “Economic Analysis of Calculation of Compensation for Intellectual Property Infringement.” For more information...

See all events

CRA opines on commercial success of dermatological product

Meet Our Team

Related Insights

CRA consultants named top IP strategists in IAM Strategy 300 2021

12 CRA consultants named top IP professionals in the 2021 IAM Patent 1000

Upcoming Events

Beijing Offline Conference - How to obtain the amount of high damage compensation for intellectual property